EZ Cap™ Cy5 EGFP mRNA (5-moUTP)
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) will express enhanced green fluorescent protein(EGFP) once entering cells originally isolated from the jellyfish(Aequorea victoria). You can observe the green fluorescence at 509 nm. EGFP is usually used as a reporter for gene regulation and function study. It is applicable in assays for mRNA delivery, translation efficiency, cell viability and in vivo imaging etc.
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) is provided at a concentration of ~1 mg/ml with Cap1 structure. There are currently two ways to cap mRNA: One is co-transcription method, by adding Cap analogues into the transcription process. The other is enzymatic Capping. After transcription, Cap0 capping is performed by Vaccinia virus Capping Enzyme (VCE), GTP and S-adenosylmethionine (SAM). The Cap0 is then generated into the Cap1 through 2´-O-Methyltransferase and SAM. Cap1 Capping can also be performed by adding VCE, 2´-O-Methyltransferase, GTP and SAM in a one-step process. Cap 1 structure is more ideal for mammalian systems and possess higher transcription efficiency than Cap 0 structure. The addition of 5-moUTP and poly(A) tail suppress RNA-mediated innate immune activation and increase the stability and lifetime of the mRNA in vitro and in vivo. Poly(A) tail also plays an important role in enhancing the efficiency of translation initiation. Cy5 is a synthetic red fluorescent dye with maximum excitation and emission wavelengths of 650 nm and 670 nm, respectively. Cy5-UTP and 5-moUTP is used in a ratio of 1:3 when transcribed. Substitution in this ratio results in mRNA that is easy to visualize and still can be translated in cell culture. In the rough, there is an anti-correlation between translation efficiency and Cy5-UTP substitution.
- 1. Harrison Lawson, Huy Nguyen, et al. "Synthetic Strategy for mRNA Encapsulation and Gene Delivery with Metal-Organic Frameworks." ChemRxiv. 12 April 2024
- 2. Zhihui Dong, Zhuoshan Huang, et al. "Nanoparticles (NPs)-mediated systemic mRNA delivery to reverse trastuzumab resistance for effective breast cancer therapy." Acta Pharmaceutica Sinica B.
- 3. Valentina Andretto, Mathieu Repellin, et al. "Hybrid core-shell particles for mRNA systemic delivery ." J Control Release. PMID: 36442614
- 4. Chen Q, Gao M, et al. "Biodegradable nanoparticles decorated with different carbohydrates for efficient macrophage-targeted gene therapy." J Control Release. 2020 Apr 22;323:179-190. PMID: 32334322
Related Biological Data

mRNA Length | 996 nucleotides | ||
Concentration | 1 mg/mL | ||
Buffer | 1 mM Sodium Citrate, pH 6.4 | Storage | -40°C or below |
General tips | Dissolve it on ice and take care to prevent RNase contamination degradation. Avoid repeated freezing and thawing as much as possible. Do not vortex. For the first time, it is gently centrifuged and divided into several parts for stand-alone use. Use RNase-free reagents and consumables, using appropriate RNase-free technology. It can not be added to the serum-containing medium until it is mixed with the transfection reagent. | ||
Shipping Condition | Evaluation sample solution : ship with dry ice. |